Index S&P 500 P/E 25.90 EPS (ttm) 5.16 Insider Own 6.55% Shs Outstand 72.04M Perf Week -5.65%
Market Cap 9.59B Forward P/E 12.22 EPS next Y 10.94 Insider Trans 0.16% Shs Float 67.05M Perf Month -1.86%
Enterprise Value 8.71B PEG 3.10 EPS next Q 2.97 Inst Own 98.29% Short Float 3.85% Perf Quarter -4.97%
Income 378.40M P/S 2.41 EPS this Y 9.20% Inst Trans 2.00% Short Ratio 2.03 Perf Half Y -22.24%
Sales 3.98B P/B 2.43 EPS next Y 7.33% ROA 6.01% Short Interest 2.58M Perf YTD -35.89%
Book/sh 54.93 P/C 9.55 EPS next 5Y 8.35% ROE 9.58% 52W High 246.19 -45.70% Perf Year -40.24%
Cash/sh 14.00 P/FCF 16.93 EPS past 3/5Y -16.61% 0.33%ROIC 9.36% 52W Low 122.00 9.57% Perf 3Y -36.44%
Dividend Est. - EV/EBITDA 10.82 Sales past 3/5Y 0.39% 10.69% Gross Margin 69.61% Volatility 2.55% 3.28% Perf 5Y -70.47%
Dividend TTM - EV/Sales 2.19 EPS Y/Y TTM -12.05% Oper. Margin 15.86% ATR (14) 4.55 Perf 10Y 103.81%
Dividend Ex-Date - Quick Ratio 1.17 Sales Y/Y TTM 0.56% Profit Margin 9.50% RSI (14) 46.97 Recom 2.00
Dividend Gr. 3/5Y - - Current Ratio 1.29 EPS Q/Q -49.48% SMA20 -1.98% Beta 1.85 Target Price 174.92
Payout 0.00% Debt/Eq 0.03 Sales Q/Q 1.82% SMA50 0.69% Rel Volume 0.82 Prev Close 132.28
Employees 20945 LT Debt/Eq 0.02 Earnings Oct 29 AMC SMA200 -18.32% Avg Volume 1.27M Price 133.68
IPO Jan 26, 2001 Option/Short Yes / Yes EPS/Sales Surpr. 8.61% 1.98% Trades
Volume 1,048,716 Change 1.06%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-10-25 Downgrade Jefferies
Buy → Hold
$140
Jul-31-25 Downgrade Morgan Stanley
Overweight → Equal-Weight
$154
Apr-25-25 Downgrade HSBC Securities
Buy → Hold
$170
Feb-14-25 Initiated Wells Fargo
Overweight
$255
Jan-06-25 Upgrade Leerink Partners
Market Perform → Outperform
$235 → $280
Dec-04-24 Initiated Mizuho
Outperform
$295
Oct-10-24 Initiated Needham
Hold
Feb-26-24 Initiated Leerink Partners
Market Perform
$310
Dec-11-23 Downgrade Goldman
Neutral → Sell
$197
Oct-27-23 Downgrade UBS
Buy → Neutral
$200
Feb-02-23 Upgrade Goldman
Sell → Neutral
$165 → $307
Jul-28-22 Downgrade Goldman
Buy → Sell
$380 → $250
Jan-31-22 Upgrade UBS
Neutral → Buy
$880 → $620
Jan-31-22 Initiated Morgan Stanley
Overweight
$575
Oct-01-21 Resumed Credit Suisse
Outperform
$732
Aug-05-21 Resumed Credit Suisse
Outperform
$732
Jul-09-21 Upgrade Stephens
Equal-Weight → Overweight
$600 → $700
Jul-08-21 Initiated Exane BNP Paribas
Outperform
$790
Apr-22-21 Upgrade Berenberg
Hold → Buy
$683
Jan-04-21 Upgrade Evercore ISI
In-line → Outperform
$625
Show Previous Ratings
Today 09:41AM
Nov-17-25 12:16PM
Nov-11-25 07:38PM
Nov-10-25 07:50AM
Nov-05-25 12:36AM
04:01PM
Loading…
Nov-04-25 04:01PM
Nov-03-25 04:02PM
Oct-30-25 01:16PM
12:26PM
12:24PM
10:09AM
09:33AM
01:34AM
Oct-29-25 05:49PM
05:30PM
05:20PM
Loading…
05:20PM
04:18PM
(Associated Press Finance)
04:03PM
04:00PM
04:00PM
12:58PM
Oct-27-25 11:17PM
Oct-23-25 10:00AM
Oct-22-25 10:00AM
Oct-20-25 08:57AM
Oct-19-25 03:21AM
Oct-16-25 12:05AM
Oct-11-25 05:15AM
Oct-10-25 03:50PM
09:36AM
01:48AM
Loading…
Oct-03-25 01:48AM
Oct-01-25 08:30AM
Sep-29-25 07:12PM
Sep-25-25 01:06PM
Sep-23-25 05:00PM
Sep-18-25 08:41AM
Sep-17-25 11:41AM
Sep-09-25 08:46PM
Aug-29-25 11:30AM
08:07AM
Aug-28-25 04:00PM
Aug-27-25 11:33PM
Aug-23-25 03:54AM
Aug-22-25 02:25PM
01:15PM
Aug-18-25 06:00PM
04:06AM
Aug-13-25 03:32PM
12:13AM
Aug-12-25 11:55PM
Aug-08-25 06:20AM
03:27AM
Aug-07-25 07:09AM
Aug-05-25 07:04PM
11:45AM
08:30AM
Aug-04-25 12:36PM
Aug-02-25 07:48AM
Aug-01-25 07:08PM
(Morningstar Research) +5.82%
06:57PM
02:36PM
09:40AM
09:35AM
08:50AM
08:43AM
Jul-31-25 04:53PM
01:42PM
12:27PM
12:22PM
11:40AM
10:07AM
08:48AM
08:46AM
05:44AM
03:32AM
12:36AM
Jul-30-25 06:00PM
05:53PM
05:30PM
04:58PM
04:34PM
(Associated Press Finance)
04:14PM
Jul-28-25 11:08PM
10:11AM
Jul-25-25 08:03PM
Jul-24-25 10:46AM
10:08AM
09:50AM
09:45AM
08:30AM
Jul-23-25 11:19AM
Jul-22-25 09:00PM
09:00PM
Jul-21-25 09:00PM
Jul-18-25 09:50AM
Jul-17-25 11:40AM
09:00AM
Jul-16-25 05:00PM
09:04AM
08:19AM
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad's CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HOGAN JOSEPH M PRESIDENT AND CEO Aug 01 '25 Buy 131.49 7,576 996,131 184,945 Aug 01 04:05 PM Conroy Kevin T Director May 21 '25 Option Exercise 0.00 1,148 0 1,808 May 22 05:49 PM SIEGEL SUSAN E Director May 21 '25 Option Exercise 0.00 1,148 0 8,978 May 22 05:14 PM Saia Andrea Lynn Director May 21 '25 Option Exercise 0.00 1,148 0 15,573 May 22 05:13 PM Poul Mojdeh Director May 21 '25 Option Exercise 0.00 1,148 0 1,808 May 22 05:12 PM Myong Anne Director May 21 '25 Option Exercise 0.00 1,148 0 8,085 May 22 05:12 PM MORROW GEORGE J Director May 21 '25 Option Exercise 0.00 1,148 0 3,291 May 22 05:11 PM LARKIN C RAYMOND JR Director May 21 '25 Option Exercise 0.00 1,531 0 25,128 May 22 05:10 PM LACOB JOSEPH Director May 21 '25 Option Exercise 0.00 1,148 0 134,171 May 22 05:09 PM Dallas Kevin J Director May 21 '25 Option Exercise 0.00 1,148 0 14,423 May 22 05:08 PM Coletti Julie Ann EVP, CHIEF LEGAL & REGULATORY Feb 20 '25 Option Exercise 0.00 3,341 0 8,033 Feb 24 06:47 PM Hockridge Stuart A EVP GLOBAL HR Feb 20 '25 Option Exercise 0.00 2,587 0 12,254 Feb 24 06:46 PM Morici John EVP & CHIEF FINANCIAL OFFICER Feb 20 '25 Option Exercise 0.00 4,539 0 17,532 Feb 24 06:45 PM HOGAN JOSEPH M PRESIDENT AND CEO Feb 20 '25 Option Exercise 0.00 21,149 0 241,489 Feb 24 06:44 PM Wright Emory Director Nov 25 '24 Proposed Sale 232.94 2,500 582,362 Nov 25 11:23 AM
